OTLK (Outlook Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Outlook Therapeutics, Inc. Common Stock (OTLK) is a publicly traded Healthcare sector company. As of May 21, 2026, OTLK trades at $0.27 with a market cap of $27.70M and a P/E ratio of -0.23. OTLK moved +18.21% today. Year to date, OTLK is -49.69%; over the trailing twelve months it is -83.94%. Its 52-week range spans $0.16 to $6.98. Analyst consensus is buy with an average price target of $3.25. Rallies surfaces OTLK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns OTLK stock?
Hedge funds tracked by Rallies that own OTLK include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Outlook Therapeutics, Inc. Common Stock.
OTLK Key Metrics
Key financial metrics for OTLK
Metric
Value
Price
$0.27
Market Cap
$27.70M
P/E Ratio
-0.23
EPS
$-1.13
Dividend Yield
0.00%
52-Week High
$6.98
52-Week Low
$0.16
Volume
385.24K
Avg Volume
0
Revenue (TTM)
$1.41M
Net Income
$-60.96M
Gross Margin
-85.05%
Top Hedge Funds Holding OTLK
Exoduspoint Capital holds 11.23K shares of OTLK, changed +0.00% as of Sep 30, 2024.
Hedge funds tracked by Rallies that own OTLK include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Outlook Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for OTLK?
Yes. Rallies tracks hedge fund and 13F ownership data for OTLK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OTLK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OTLK. It does not provide personalized investment advice.
